Log in

Study programmes

Pharmacology and Toxicology

Study program:
Pharmacology and Toxicology
SP code:
P0916D350001
Study form:
full-time
Study type:
doctoral
Standard duration of study in years:
4
Language of instruction:
Czech
Title:
Ph.D.
Title:
No
More details
SP name in English:
Pharmacology and Toxicology
SP name in Latin:
Pharmacologia et toxicologia
SP profile:
academically oriented

SP characteristics

Pharmacology and toxicology are sciences that study the mechanisms of mutual interactions of substances and medicinal preparations with biologic systems and observe their both favourable and adverse impact on the organism. The final goal is the use of this knowledge in prevention, diagnosis and treatment of human and veterinary conditions.
A great advantage of the study of pharmacology and toxicology is the close interconnection of the theoretic field with all clinical specialties that perform therapy, prevention and diagnosis. The study programme in Pharmacology and Toxicology is therefore suitable not only for those interested in experimental research but also for those seeking their prospective careers in clinical work. The main bias of the study programme, nevertheless, is experimental, at both the pre-clinical and clinical level.
The goal of the doctoral programme Pharmacology and Toxicology is training specialists with deep knowledge in the areas of clinical as well experimental pharmacology and toxicology. This envelops knowledge of wide areas of pharmacokinetics, pharmacodynamics, effects and toxicity of medications, including the knowledge of properties of particular forms of medicinal preparations.
More details
Graduate profile for the public:
Graduates of the doctoral program Pharmacology and toxicology obtained complete and unique overview on general and specific mechanisms of drug activity, pharmacodynamics, pharmacokinetics and drug toxicity as well as on application of the drug characteristics during their use. They understand the use of mathematical and statistical models in drug development or description of drug effects.

Related accreditations

Faculty Name of the study program Language of instruction Study form
2. lékařská fakulta Farmakologie a toxikologie čeština kombinovaná
3. lékařská fakulta Pharmacology and Toxicology angličtina prezenční
1. lékařská fakulta Pharmacology and Toxicology angličtina prezenční
2. lékařská fakulta Pharmacology and Toxicology angličtina prezenční
3. lékařská fakulta Pharmacology and Toxicology angličtina kombinovaná
1. lékařská fakulta Farmakologie a toxikologie čeština kombinovaná
1. lékařská fakulta Pharmacology and Toxicology angličtina kombinovaná
2. lékařská fakulta Pharmacology and Toxicology angličtina kombinovaná
3. lékařská fakulta Farmakologie a toxikologie čeština kombinovaná

Teaching provided by

Faculty:
Cooperating institutions:
  • Institutions:
  • Institute of Physiology of the CAS
  • Institute of Experimental Medicine of the CAS
  • Institute of Organic Chemistry and Biochemistry of the CAS
More details
Foreign university joint diploma type:
No
External department:
No

Classification

Area of education:
  • General Medicine and Dentistry
  • Pharmacy
  • Biology, Ecology and The Environment
  • Healthcare Fields

SP structure

Specialisation:
No
Double-curriculum study:
No
Data for persons with disabilities
Contact person for persons with disability:
prof. MUDr. Ondřej Slanař, Ph.D.
Web page for persons with disability:
https://www.lf1.cuni.cz/studenti-se-specialnimi-potrebami-uchazeci-lf1
Further information about the study of persons with disability:

Personal provision

Garant SP:
  • prof. MUDr. Ondřej Slanař, Ph.D.
More details
Subject Area Board Members:
  • Chairman, Slanař Ondřej, prof. MUDr., Ph.D. (from 15.1.2020)
  • Members, Balíková Marie, doc. Ing., CSc. (from 5.2.2020)
  • Members, Büchler Tomáš, prof. MUDr., Ph.D. (from 28.2.2022)
  • Members, Bultas Jan, prof. MUDr., CSc. (from 5.2.2020)
  • Members, Canová Nikolina, MUDr., Ph.D. (from 5.2.2020)
  • Members, Čabala Radomír, doc. RNDr., Dr. (from 5.2.2020)
  • Members, Farghali Hassan, prof. Dr., DrSc. (from 5.2.2020)
  • Members, Juřica Jan, doc. PharmDr., Ph.D. (from 5.2.2020)
  • Members, Kmoníčková Eva, doc. RNDr., CSc. (from 5.2.2020)
  • Members, Mičuda Stanislav, prof. MUDr., Ph.D. (from 5.2.2020)
  • Members, Mysliveček Jaromír, prof. MUDr., Ph.D., MBA (from 5.2.2020)
  • Members, Nesměrák Karel, doc. RNDr., Ph.D. (from 5.2.2020)
  • Members, Novotný Jiří, doc. RNDr., DSc. (from 5.2.2020)
  • Members, Paluch Zoltán, doc. MUDr., Ph.D., MBA (from 5.2.2020)
  • Members, Souček Pavel, prof. RNDr., CSc. (from 5.2.2020)
  • Members, Svoboda Petr, doc. RNDr., DrSc. (from 5.2.2020)
  • Members, Šíma Martin, doc. PharmDr., Ph.D. (from 17.10.2025)
  • Members, Šustková Magdaléna, doc. PharmDr. Bc., CSc. (from 5.2.2020)
  • Members, Živný Jaroslav, prof. MUDr., DrSc. (from 5.2.2020)
  • Former/future members of SAB:
  • Members, Perlík František, prof. MUDr., DrSc. (5.2.2020 - 7.11.2020)

Instruction

Admission procedure requirements:
Study programme (branch) is open for applicants for the academic year 2026/2027:
Admission procedure requirements in the acaademic year 2025/2026:

Can be studied in combination

No combinations have been found
EU MŠMT